323 related articles for article (PubMed ID: 35731648)
1. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
[No Abstract] [Full Text] [Related]
2. Regression models for predicting physical and EQD
Wang H; Zhou Y; Gan W; Chen H; Huang Y; Duan Y; Feng A; Shao Y; Gu H; Kong Q; Xu Z
Radiat Oncol; 2021 Jun; 16(1):119. PubMed ID: 34176503
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal Cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
[TBL] [Abstract][Full Text] [Related]
5. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
[TBL] [Abstract][Full Text] [Related]
8. Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer.
Slevin F; Thompson CM; Speight R; Murray LJ; Lilley J; Henry AM
Med Dosim; 2021 Winter; 46(4):411-418. PubMed ID: 34148727
[TBL] [Abstract][Full Text] [Related]
9. Isotoxic investigation of
Shao Y; Chen H; Wang H; Feng A; Huang Y; Kong Q; Xu Z
Int J Radiat Biol; 2021; 97(12):1641-1648. PubMed ID: 34597214
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
11. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate.
Bansal A; Kapoor R; Singh SK; Kumar N; Oinam AS; Sharma SC
Indian J Urol; 2012 Jul; 28(3):300-6. PubMed ID: 23204659
[TBL] [Abstract][Full Text] [Related]
13. Myths, facts and scope of spinal cord tolerance dose revision in Intensity modulated SIB treatment of locally advanced head and neck cancer: A dosimetrical and radiobiological demonstration.
Patel G; Mandal A; Choudhary S; Mishra R; Shahi U; Mishra H
Cancer Radiother; 2021 Feb; 25(1):8-12. PubMed ID: 33293203
[TBL] [Abstract][Full Text] [Related]
14. SBRT combined with concurrent chemoradiation in stage III NSCLC: Feasibility study of the phase I Hybrid trial.
Peulen H; Franssen G; Belderbos J; van der Bijl E; Tijhuis A; Rossi M; Sonke JJ; Damen E
Radiother Oncol; 2020 Jan; 142():224-229. PubMed ID: 31431387
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and radiobiological comparison of IMRT, VMAT, and helical tomotherapy planning techniques in hippocampal sparing whole brain radiotherapy with simultaneous integrated boost for multiple brain metastases.
Balasubramanian S; Shobana MK; Anabalagan D; Thanasekar P; Joel S; Chaudhary P
Radiat Environ Biophys; 2024 Mar; 63(1):47-57. PubMed ID: 38194100
[TBL] [Abstract][Full Text] [Related]
17. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a Hybrid IMRT/VMAT technique with non-coplanar VMAT and non-coplanar IMRT for unresectable olfactory neuroblastoma using the RayStation treatment planning system-EUD, NTCP and planning study.
Raturi VP; Motegi A; Zenda S; Nakamura N; Hojo H; Kageyama SI; Okumura M; Rachi T; Ohyoshi H; Tachibana H; Motegi K; Ariji T; Nakamura M; Hirano Y; Hirata H; Akimoto T
J Radiat Res; 2021 May; 62(3):540-548. PubMed ID: 33839761
[TBL] [Abstract][Full Text] [Related]
19. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
20. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
